濮阳东方医院看早泄评价很好(濮阳东方看男科病技术值得放心) (今日更新中)

SAN FRANCISCO, Nov. 12 (Xinhua) -- Apple has unveiled a worldwide replacement program for the first-generation iPod nano music player due to overheating battery issues, telling owners to stop using the product and get it replaced for free."Apple has determined that, in very rare cases, the battery in the iPod nano (1st generation) may overheat and pose a safety risk. Affected iPod nanos were sold between September 2005 and December 2006," said Apple in a notice posted late Friday on the support section of its official website.The company said the issue has been traced to a single battery supplier that produced batteries with a manufacturing defect. Since the product is five or six years old now, the likelihood of an incident increases.Owners of iPod nano can check the serial number on the back of the product to see if it is eligible for replacement. Apple promises a replacement unit about six weeks after the company received the affected one.The overheating battery issues of the first generation iPod nano have been known for years. In 2008, Japan's Ministry of Economy, Trade and Industry launched an investigation into Apple after dozens of iPod overheating cases were reported, including several incidents of iPod nanos toasting to the point of catching fire and causing minor burns to owners.Last August, a commuter train in Tokyo was delayed during rush hour when passengers complained of a strong burning smell from an overheating iPod nano that had burst apart.The portable music player also cost Apple a 22.5 million-U.S. dollar settlement in 2009 when a class action lawsuit in California alleged iPod nano is prone to scratches and its alleged defects were not disclosed by the company.

RIYADH, Jan. 15 (Xinhua) -- Visiting Chinese Premier Wen Jiabao and Saudi Arabia's King and Prime Minister Abdullah bin Abdul-Aziz agreed on Sunday to make concerted efforts to enhance bilateral relations under a strategic framework.In their meeting, Premier Wen said Saudi Arabia is a major country in the Arab and Islamic world, which plays a significant role in regional and international affairs.He said China respects Saudi Arabia's political system, development mode as well as its culture and traditions, and is grateful for Saudi Arabia's understanding of and support for China regarding the latter's core interests and major concerns.As the world is undergoing profound changes, China is willing to strengthen coordination with Saudi Arabia on major issues, develop an all-around cooperative partnership in the energy sector, expand cooperation in trade, investment, infrastructure, high-tech, finance, security and law enforcement, so as to enrich the contents of the bilateral relations, he added.King Abdullah said that the government and people of Saudi Arabia cherish friendly feelings for China, and that he believes the strengthening of bilateral cooperation will benefit peoples of both countries.The Saudi king proposed setting up a Saudi Arabia-China high level committee to supervise the two countries' cooperation in the political, economic, cultural and security sectors. Premier Wen agreed with this proposal.On the situation in West Asia and North Africa, the visiting Chinese premier said China respect the choice of the peoples in those countries, understand and support their appeal for reforms, and back the role of regional bodies like the Arab League in maintaining stability.For his part, King Abdullah noted it was the objective of Saudi Arabia's foreign policy to maintain regional peace and stability. Saudi Arabia and China enjoy a high level of mutual trust and share similar views on many issues, he said, adding that the Saudi side wishes to step up consultation and coordination with China.Premier Wen has also met with top Saudi leaders, Secretary General of the Organization of Islamic Cooperation Ekmeleddin Ihsanoglu, and Secretary General of the Gulf Cooperation Council Abdullatif al-Zayani.In a joint statement, the two sides hailed Premier Wen's visit to Saudi Arabia as a complete success, which will contribute to their long-term friendly cooperative relations.The statement said both countries were satisfied with the progress made in bilateral cooperation, and pledged to further enhance relations within the framework of strategic relationship, so as to benefit the two peoples and contribute to regional and world peace, stability and development.The two countries agreed in the document to conduct more high-level exchanges of visits, and to expand trade, investment and cooperation in a wide range of areas. The Saudi side also reiterated its adherence to the one-China policy.Wen arrived in Saudi Arabia Saturday evening after an official visit to Nepal.After his stay in Saudi Arabia, the Chinese leader will continue his visit to the United Arab Emirates and Qatar.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

BEIJING, Dec. 25 (Xinhua) -- A total of 14,976 cases of medical disputes were handled by the country's emerging third-party mediation organizations, with over 80 percent of them being successfully settled, said Vice Health Minister Zhang Mao.Zhang told Xinhua recently in an exclusive interview that China has to date set up 1,358 third-party mediation organizations to settle medical disputes.The third-party mediation organizations have come into being since late 2009 which usually hire retired doctors, medical experts and lawyers to bridge the communication gaps between doctors and patients and direct patients to resort to legal means in settling medical disputes.The third-party mediation system for medical disputes is a latest reform to ease doctor-patient tension that sometimes escalate into violence.Such incidents erupted several times this year, and in an extreme case in September, a 43-year-old surgeon in Beijing Tongren Hospital was stabbed by a patient into serious injury. The attack was believed to have been triggered by a medical dispute in which the patient alleged that the surgeon had committed malpractice during an operation.

ISLAMABAD, Oct. 24 (Xinhua) -- Samina, 38, was shocked when doctor told her that she has been suffering from breast cancer for three years and due to late diagnosis the disease spread into her bones making the chances of survival very slim.Samina said that she is trying hard to fight the disease, at the same time she holds the doctors of her village responsible for failing to diagnose the disease in three long years. She is also concerned about her three kids too young to accept any bitter reality."I can't see the distressed faces of my children, I can't bear the fear that looms in their eyes, they know that with every coming day their mother is moving a step forward to death," Samina told Xinhua in a very low tone.When Samina and all other patients of that gloomy medical ward for breast cancer patients, in Nuclear Medicine Oncology and Radiography (NORI) hospital in Islamabad, were told that October is being observed as breast cancer awareness month they murmured that the awareness message should be reached to every nook and corner of the country this year so that no other woman would die due to unawareness.In a country like Pakistan where one in nine women is prone to breast cancer and around 40,000 women die every year due to lack of awareness of this disease. They come to visit oncology department of hospitals at a stage when the chances of survival are very remote.Omer Aftab, National Coordinator of the Pink Ribbon, said that Pakistan has the highest rate of breast cancer among Asian nations. It is the most common malignancy in women, and accounts for 38.5 percent of all female cancer patients, with 90,000 new cases every year.

来源：资阳报